Skip directly to content

Plasma Biomarkers May Identify Risk for Dementia

Viernes, Septiembre 11, 2020

Plasma amyloid and neurofilament levels were associated with dementia risk in a population-based cohort.

Assessment of plasma biomarkers is emerging as a potential noninvasive way to determine risk for dementia.

 

 


NEJM Journal Watch summary, reutilizado con permiso del Grupo NEJM.

 

Código de aprobación: PP-CNS-CHL-0014